Zegalogue Uses, Dosage, Side Effects and more
Zegalogue is under investigation in clinical trial NCT03735225 (Evaluation of the Safety, Tolerability and Bioavailability of Zegalogue Following Subcutaneous (SC) Compared to IV Administration).
| Trade Name | Zegalogue |
| Availability | Prescription only |
| Generic | Dasiglucagon |
| Dasiglucagon Other Names | Dasiglucagon |
| Related Drugs | glucagon, Baqsimi, diazoxide, Gvoke, GlucaGen, Proglycem |
| Type | Injection, For Subcutaneous Use, Solution |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States, |
| Last Updated: | January 7, 2025 at 1:49 am |
Disease Interaction
Major: insulinoma, pheochromocytomaModerate: glycogen depletion
